Skip to content
Inquiries: (734) 926-0465
MI Bioresearch
  • About
    • Company
    • Leadership Team
    • News and Events
      • Press
      • Events
      • Blog
    • Careers
    • Location
    • Contact
  • Services
    • Oncology Pharmacology
      • Cell Line List
      • Subcutaneous Models
      • Orthotopic Models
      • Metastasis Models
      • Disseminated Models
      • PDX Models
    • Immuno-Oncology
    • Adoptive Cell Therapy
    • In Vitro Services
      • Immunohistochemistry
    • Flow Cytometry
    • Imaging
    • Radiation
    • In Vivo Biodistribution
      • Biologics
      • Gene Tracking
    • Other Therapeutic Areas
      • Fibrosis
  • Tumor Models
    • Complete Cell Line List
    • Human Cancer Cell Lines and Growth Curves
    • Syngeneic Cancer Cell Lines and Growth Curves
  • Immuno-Oncology
    • Overview
    • Syngeneic Cancer Cell Lines and Growth Curves
    • Flow Cytometry
    • Radiation Therapy
    • Exogenous T-Cell Tracking
  • Imaging
    • Overview
    • Bioluminescence Imaging (BLI)
    • Fluorescence Imaging (FLI)
    • Positron Emission Tomography (PET)
    • Computed Tomography (CT)
    • Image Analysis Services
  • Knowledge Center
    • View All Resource Types
    • Blog
    • Model Spotlights
    • Posters
    • Publications
    • Tech Spotlights
    • Webinars
  • Contact
_

Luciferase

Home / Luciferase

Share

Targeting B Cell Malignancies? Raji-Luc is a Model to Test CD19-Directed CAR-T Cells and Other Novel Approaches

Anti-tumor Activity of Anti-CD20 Monoclonal Antibody—Rituximab Similar to CD19, CD20 is also a marker of B cells and was an initial target of drugs focusing on B cell malignancies like Non-Hodgkin’s lymphoma. The clinical development of the anti-CD20 monoclonal antibody, rituximab, proved ground-breaking for use of monoclonal antibodies as oncology […]

134
  • Knowledge Center
    • View All Resource Types
    • Blog
    • Model Spotlights
    • Posters
    • Publications
    • Tech Spotlights
    • Webinars

Contact Us

Stay Connected
Get the latest FREE news updates direct to your inbox.

Sign Up
Copyright 2019 MI Bioresearch Inc
  • Privacy Policy
  • Terms and Conditions
  • Sitemap
  • About
    • Company
    • Leadership Team
    • News and Events
      • Press
      • Events
      • Blog
    • Careers
    • Location
    • Contact
  • Services
    • Oncology Pharmacology
      • Cell Line List
      • Subcutaneous Models
      • Orthotopic Models
      • Metastasis Models
      • Disseminated Models
      • PDX Models
    • Immuno-Oncology
    • Adoptive Cell Therapy
    • In Vitro Services
      • Immunohistochemistry
    • Flow Cytometry
    • Imaging
    • Radiation
    • In Vivo Biodistribution
      • Biologics
      • Gene Tracking
    • Other Therapeutic Areas
      • Fibrosis
  • Tumor Models
    • Complete Cell Line List
    • Human Cancer Cell Lines and Growth Curves
    • Syngeneic Cancer Cell Lines and Growth Curves
  • Immuno-Oncology
    • Overview
    • Syngeneic Cancer Cell Lines and Growth Curves
    • Flow Cytometry
    • Radiation Therapy
    • Exogenous T-Cell Tracking
  • Imaging
    • Overview
    • Bioluminescence Imaging (BLI)
    • Fluorescence Imaging (FLI)
    • Positron Emission Tomography (PET)
    • Computed Tomography (CT)
    • Image Analysis Services
  • Knowledge Center
    • View All Resource Types
    • Blog
    • Model Spotlights
    • Posters
    • Publications
    • Tech Spotlights
    • Webinars
  • Contact

Share: Targeting B Cell Malignancies? Raji-Luc is a Model to Test CD19-Directed CAR-T Cells and Other Novel Approaches

#
Stay Connected

Get the latest updates from MI Bioresearch direct to your inbox by registering for our FREE newsletter.